Please find below our posters presented at ISPOR 2017 (Glasgow):
- Biosimilar uptake in the UK - an evolving story?
- 12 month review of NICE and SMC recommendations for new technologies
- Are we PrEP-ared for differences between NICE and SMC decision making?
- Are patient outcomes being relegated by the NICE Budget Impact Test?
- Shouldn't NICE cost-effectiveness thresholds be changing with the times?
- Will 2017 updates to the Highly-Specialised Technologies programme benefit or harm vulnerable patients?